1. LncRNA: Shedding light on mechanisms and opportunities in fibrosis and aging
   Zhi Yang et al, 2019, Ageing Research Reviews CrossRef
2. Long non‐coding RNAs: Promising new targets in pulmonary fibrosis
   Songzi Zhang et al, 2021, The Journal of Gene Medicine CrossRef
3. Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs
   Marina R. Hadjicharalambous et al, 2020, International Journal of Molecular Sciences CrossRef
4. Decrypting the crosstalk of noncoding RNAs in the progression of IPF
   Yujuan Wang et al, 2020, Molecular Biology Reports CrossRef
5. The function of non-coding RNAs in idiopathic pulmonary fibrosis
   Hui Zhang et al, 2021, Open Medicine CrossRef
6. Molecular genetics of idiopathic pulmonary fibrosis
   R. N. Mustafin, 2022, Vavilov Journal of Genetics and Breeding CrossRef
7. Ribosomal protein S6 kinase 2 (RPS6KB2) is a potential immunotherapeutic target for cancer that upregulates proinflammatory cytokines
   Qiang Ma et al, 2024, Molecular Biology Reports CrossRef
8. Non-coding RNA in idiopathic interstitial pneumonia and Covid-19 pulmonary fibrosis
   Mohammad Shadab Ali et al, 2022, Molecular Biology Reports CrossRef
9. Prospects for Treatment of Idiopathic Pulmonary Fibrosis
   R. N. Mustafin, 2022, The Russian Archives of Internal Medicine CrossRef
10. lncITPF Promotes Pulmonary Fibrosis by Targeting hnRNP-L Depending on Its Host Gene ITGBL1
    Xiaodong Song et al, 2019, Molecular Therapy CrossRef
11. LncRNA CTD-2528L19.6 prevents the progression of IPF by alleviating fibroblast activation
    Tingting Chen et al, 2021, Cell Death & Disease CrossRef
12. Identification of differentially expressed proteins in the injured lung from zinc chloride smoke inhalation based on proteomics analysis
    Xiaowei Xie et al, 2019, Respiratory Research CrossRef
13. Telomeric repeat-containing ribonucleic acid (TERRA) expression in patients with idiopathic pulmonary fibrosis
    Manal M. El-Desoky et al, 2021, Egyptian Journal of Medical Human Genetics CrossRef
14. Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
    Hongbo Ma et al, 2022, Frontiers in Pharmacology CrossRef